Skip to main navigation Skip to search Skip to main content

Ventricular tachycardia/ventricular fibrillation ablation in the setting of ischemic heart disease

  • Francis Marchlinski
  • , Fermin Garcia
  • , Amir Siadatan
  • , William Sauer
  • , Stuart Beldner
  • , Erica Zado
  • , Henry Hsia
  • , David Lin
  • , Joshua Cooper
  • , Ralph Verdino
  • , Edward Gerstenfeld
  • , Sanjay Dixit
  • , Andrea Russo
  • , David Callans

Research output: Contribution to journalArticlepeer-review

Abstract

Ventricular Tachycardia Ablation in Coronary Disease. Recurrent ventricular tachycardia (VT) in the setting of coronary artery disease is frequently a life-threatening electrophysiologic emergency. Even in patients with an implantable defibrillator, recurrent VT is frequently accompanied by repeated and disabling shock therapy. Catheter ablative therapy offers the ability to provide immediate control of recurrent VT. Long-term elimination of VT should be anticipated in most patients. This article reviews the strategies, tools, techniques, and expected outcome for catheter ablation of stable and unstable ventricular arrhythmias in the setting ischemic heart disease.

Original languageEnglish (US)
Pages (from-to)S59-S70
JournalJournal of Cardiovascular Electrophysiology
Volume16
Issue numberSUPPL. 1
DOIs
StatePublished - Sep 2005
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Fingerprint

Dive into the research topics of 'Ventricular tachycardia/ventricular fibrillation ablation in the setting of ischemic heart disease'. Together they form a unique fingerprint.

Cite this